Fournier's European Strategy
Executive SummaryTo reduce its dependence on a stagnant and price sensitive French market, Fournier has created a low-risk R&D program coupled with an aggressive international acquisition program. The program attempts to take advantage of small-market research opportunities as well as acquisition targets overlooked by large companies or which fall out of mega-mergers. Is this gamble enough to ensure independence for a mid-sized player?
You may also be interested in...
Hoping to avoid litigation discovery, sponsors ask FDA for avenue to explain patent issues during labeling discussions without written record; negotiations for BsUFA III may be opportunity to create such a process.